United Therapeutics Stock Target Price and Analyst Consensus
| UTHR Stock | USD 367.36 3.03 0.83% |
The current analyst and expert consensus on United Therapeutics is Buy with 5 hold recommendations. The current projected United Therapeutics target price consensus is 284.60 with 16 analyst opinions. One of the most common ways United Therapeutics analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to United Therapeutics vendors, executives, and/or customers. United Therapeutics recommendation module provides expert sentiment on the projected United Therapeutics target price to derive its highest and lowest estimates based on target price standard deviation of 1.7389.
Lowest Forecast 258.99 | Highest Forecast 315.91 | Target Price 284.6 |
United |
It's important to approach United Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize United Therapeutics price targets
United Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using United Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at United Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if United Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional United Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of United Therapeutics is a key component of United Therapeutics valuation and have some predictive power on the future returns of a United Therapeutics.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Power Assets Invested over 200 shares | |
 | Adviser Favorites Invested few shares | |
 | Hedge Favorites Invested few shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Momentum Invested over 200 shares | |
 | FinTech Invested over 40 shares | |
 | Automobiles and Trucks Invested over 50 shares | |
 | Giant Impact Invested few shares | |
 | Housewares Invested few shares | |
 | Military Industrial Sold few shares | |
 | Artificial Intelligence Invested few shares | |
 | Chemicals Invested over 30 shares | |
 | Baby Boomer Prospects Invested over 40 shares | |
Additional Tools for United Stock Analysis
When running United Therapeutics' price analysis, check to measure United Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy United Therapeutics is operating at the current time. Most of United Therapeutics' value examination focuses on studying past and present price action to predict the probability of United Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move United Therapeutics' price. Additionally, you may evaluate how the addition of United Therapeutics to your portfolios can decrease your overall portfolio volatility.